Catabasis Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
GEORGE JEAN director
 Common Stock 258,776 $12 $3,105,312
Purchase
LAUFER RON director, 10 percent owner
 Common Stock 223,439 $12 $2,681,268
Purchase
CLARUS LIFESCIENCES II, L.P. 10 percent owner
 Common Stock 376,695 $12 $4,520,340
Purchase
SVLSF V, LLC 10 percent owner
 Common Stock 391,090 $12 $4,693,080
Purchase
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock 223,439 $12 $2,681,268
Purchase
GALAKATOS NICHOLAS director
 Common Stock 376,695 $12 $4,520,340

Showing 1 to 6 of 6 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: